SHD Partners

SHD Partners is a venture capital firm based in Dallas, Texas, focusing on early-stage investments in medical technology companies that address unmet clinical needs in healthcare. The firm seeks U.S.-based companies developing easily adoptable technologies aimed at improving patient outcomes while minimizing economic burdens. SHD Partners maintains strong relationships with its portfolio companies, providing them with the necessary skills, disciplines, and experience to succeed. The firm offers a unique investment opportunity to its limited partners, focusing on medical devices and leveraging significant Qualified Small Business tax advantages.

Founded in 2006, SHD Partners has a history of successful investments, including the Palmaz® stent, the world's first coronary stent, which created the multi-billion dollar stent market. The firm was co-founded by Philip Romano, a renowned restaurateur and investor, and Stuart Fitts, a Dallas businessman. In 2007, Andrew Offer joined the firm, bringing expertise in healthcare valuation and reimbursement analysis. Over the past 18 years, SHD Partners has grown its team and refined its investment thesis, staying true to its core focus on early-stage innovative medical technologies.

The firm's investment strategy emphasizes companies that require smaller amounts of funding and have attainable, near-term value inflection points that could lead to an exit. SHD Partners provides a differentiated investment opportunity to its limited partners, offering medical device-focused exposure to early-stage private companies that are shielded from the short-term volatility of public markets. The firm has invested in multiple fund portfolios and has become a top early-stage medtech venture capital firm, maintaining productive relationships with its portfolio companies and offering a range of skills, disciplines, and experience needed by young, capital-efficient companies.